Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2002 • 15,184 citations

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

1989 • 3,239 citations

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

2014 • 1,966 citations

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

2012 • 1,884 citations

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement

2016 • 1,867 citations

Breast Cancer Screening for Women at Average Risk

2015 • 1,477 citations

A breast cancer prediction model incorporating familial and personal risk factors

2004 • 1,203 citations

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease

2001 • 1,081 citations

Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

2002 • 1,016 citations

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

2012 • 914 citations

Breast-Cancer Screening — Viewpoint of the IARC Working Group

2015 • 816 citations

Cost of Care for Elderly Cancer Patients in the United States

2008 • 679 citations

Family history and the risk of breast cancer: A systematic review and meta-analysis

1997 • 612 citations

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

2010 • 543 citations

Benefits and Harms of Breast Cancer Screening

2015 • 532 citations

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

2015 • 520 citations

Risk Factors for Breast Cancer for Women Aged 40 to 49 Years

2012 • 391 citations

Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores

2006 • 372 citations

Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation

2016 • 356 citations

Prevalence of Mammographically Dense Breasts in the United States

2014 • 342 citations

Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status

2013 • 341 citations

Performance Benchmarks for Screening Mammography

2006 • 329 citations

Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness

2011 • 306 citations

Alcohol consumption and ethyl carbamate

2010 • 293 citations

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

2016 • 252 citations

Identifying Women With Dense Breasts at High Risk for Interval Cancer

2015 • 238 citations

Nurses' Health Study: Log-Incidence Mathematical Model of Breast Cancer Incidence

1996 • 213 citations

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer

2015 • 206 citations

Retrospective Cost-effectiveness Analysis of Screening Mammography

2006 • 194 citations

Breast cancer risk associated with benign breast disease: systematic review and meta-analysis

2015 • 193 citations

Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy

2013 • 192 citations

Mammographic Screening Programmes in Europe: Organization, Coverage and Participation

2012 • 163 citations

Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model

2006 • 158 citations

Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality

2014 • 140 citations

Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits

2014 • 137 citations

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography

2014 • 137 citations

The impact of a breast cancer screening programme on quality‐adjusted life‐years

1991 • 129 citations

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer

2014 • 125 citations

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

2012 • 115 citations

Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

2006 • 86 citations

Chapter 8: The SPECTRUM Population Model of the Impact of Screening and Treatment on U.S. Breast Cancer Trends From 1975 to 2000: Principles and Practice of the Model Methods

2006 • 69 citations

Modeling the dissemination of mammography in the United States

2005 • 68 citations

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age–Period–Cohort Model

2015 • 65 citations

Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis

2015 • 59 citations

Chapter 2: Dissemination of Adjuvant Multiagent Chemotherapy and Tamoxifen for Breast Cancer in the United States Using Estrogen Receptor Information: 1975-1999

2006 • 58 citations

Chapter 5: Additional Common Inputs for Analyzing Impact of Adjuvant Therapy and Mammography on U.S. Mortality

2006 • 44 citations

Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies

2014 • 38 citations

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index: Figure 1.

2015 • 32 citations